Dublin-based pharmaceutical company Iterum Therapeutics plc is making strides in the field of anti-infectives. The clinical-stage firm operates in Ireland, Bermuda, and the US, with a particular focus on developing and marketing anti-infectives. Its latest project, sulopenem, is a fresh anti-infective compound offered in both oral and IV formulations. Currently in Phase III clinical trials, sulopenem is being developed for the treatment of uncomplicated urinary tract infections, complicated urinary tract infections, and complicated intra-abdominal infections. Iterum Therapeutics plc was established in 2015, and is now notching up significant progress in its anti-infectives work.
Iterum Therapeutics plc's ticker is ITRM
The company's shares trade on the NASDAQ stock exchange
They are based in Dublin, Ireland
There are 11-50 employees working at Iterum Therapeutics plc
It is https://www.iterumtx.com/
Iterum Therapeutics plc is in the Healthcare sector
Iterum Therapeutics plc is in the Biotechnology industry
The following five companies are Iterum Therapeutics plc's industry peers: